The Lancet Planetary Health, Volume 6, February 2022

This is an article on the relationships between climate and clean-air policies and future health burdens in China, in the context of SDGs 3 and 11, focusing specifically on reducing the human health effects from air pollution.
In this paper, the authors assess the impact of degrading air quality on modal shares and equivalent CO2 emissions per capita per trip for ten global cities using a scenario-based approach.
Efficiency, consistency and sufficiency as complementary strategies for sustainable mobility.

Transportation Research Part D: Transport and Environment, Volume 103, February 2022

This paper proposes a method for implementing personal mobility budgets to achieve twin goals of carbon reduction (climate action) and transport justice (equity).
Map of study areas with changes in annual mean of PM2·5 from 2014 to 2017

The Lancet Healthy Longevity, Volume 3, February 2022

This is an article on the associations between long-term exposure to air pollution and cognitive ageing, in the context of SDGs 3 and 11, focusing specifically on the effects of implementing a national clean air policy on ambient concentrations of particulate matter and cognitive function in older adults across China.

The Lancet Planetary Health, Volume 6, February 2022

This is a review on food systems in small island developing states, in the context of SDGs 3, 12, and 13, focusing on the challenges of reclaiming traditional, plant-based, climate-resilient food systems to stabilise local food sectors, reduce impoverishment and food insecurity during natural disasters, increase diet quality, and decrease risk of type 2 diabetes.
Elsevier, Transportation Research Part A: Policy and Practice, Volume 156, February 2022
Much research has been devoted to assessing the effect of commute duration on the subjective well-being of people, but as of yet, the respective body or research has been inconclusive as to whether there is indeed a (large) negative effect or not. To control the spread of COVID-19 governments around the world have taken unprecedented measures to control the outbreak of the Corona-virus. Forcing or strongly advising people to work from home (i.e. at least those who can) is often one of these.
Elsevier, Translational Oncology, Volume 16, February 2022
Advocacy engagement has been at the forefront of National Cancer Institute (NCI) efforts to advance scientific discoveries and transform medical interventions. Nonetheless, the journey for advocates has been uneven. Case in Point: NCI publication affiliation rules of engagement pose unique equity challenges while raising questions about structural representation in biomedical research.
Elsevier, Studies in History and Philosophy of Science, Volume 91, February 2022
Double standards are widespread throughout biomedicine, especially in research on reproductive health. One of the clearest cases of double standards involves the feminine gendering of reproductive responsibility for contraception and the continued lack of highly effective, reversible methods for cisgender men. While the biomedical establishment accepts diversity and inclusion as important social values for clinical trials, their continued use of inequitable standards undermines their ability to challenge unfair social hierarchies by developing male contraception.